The Man on Glucocorticoids With a Normal-Looking Spine
A 58-year-old man with rheumatoid arthritis has been on prednisone 10 mg daily for 14 months. He also takes a PPI and has a 30-pack-year smoking history. He has no prior fracture. DXA shows lumbar spine T-score −1.1, total hip −1.3, femoral neck −1.4. The spine image shows mild degenerative change but no fracture. His rheumatologist asks whether he needs osteoporosis treatment, noting the T-scores are 'just osteopenia.' A FRAX calculation without BMD gives a 10-year major osteoporotic fracture probability of 11% and hip fracture probability of 2.1%.
1. Does this man meet criteria for treatment? Address the glucocorticoid issue specifically.
Read the worked answer
Yes - treat. This is a case where T-score thresholds mislead.
Key points:
- Glucocorticoid-induced osteoporosis (GIOP): ISCD and specialty guidance support treatment in adults on prednisone ≥2.5 mg/day for ≥3 months who have a history of fragility fracture, or who are at high risk by FRAX, or in some frameworks simply based on age and dose. A 58-year-old man on 10 mg daily for 14 months is squarely in the at-risk group. GIOP causes rapid early bone loss and fractures at higher BMD than postmenopausal osteoporosis - vertebral fractures occur at T-scores that would be 'osteopenic' in other contexts.
- FRAX caveat: FRAX does not fully capture glucocorticoid dose or duration; the 11% major osteoporotic probability understates risk in a patient on chronic steroids. The FRAX input for glucocorticoids is a yes/no, not dose-adjusted.
- Other risk factors: smoking, PPI (possible hypomagnesemia/calcium malabsorption), rheumatoid arthritis itself (an independent FRAX risk factor), and male sex with hypogonadism to be ruled out.
So the 'just osteopenia' framing is wrong. Treatment is indicated on clinical grounds regardless of the T-score.
2. What additional evaluation and monitoring would you recommend, and what does the DXA report need to convey?
Read the worked answer
Additional evaluation:
- Secondary causes: testosterone (hypogonadism), vitamin D, calcium, PTH, TSH, celiac screen if indicated, 24-hour urine calcium if considering treatment.
- Vertebral imaging (VFA or lateral radiograph) - GIOP vertebral fractures are common and often asymptomatic; a normal DXA spine image does not exclude them.
- Review PPI necessity and smoking cessation.
DXA report should convey:
- The T-scores as measured, but with an explicit statement that in the setting of chronic glucocorticoid use, fracture risk is elevated beyond what the T-score suggests, and that treatment is indicated on clinical grounds.
- Note the limitation of FRAX in glucocorticoid users.
- Recommend vertebral imaging if not done.
Monitoring: Repeat DXA in 1–2 years on therapy, using the same scanner and software, and compare against the facility's LSC. Do not over-interpret small changes. The report should make clear that the decision to treat was clinical, not densitometric, so that future readers do not mistakenly conclude the treatment was inappropriate because the T-score was 'only' osteopenic.